Bicycle Therapeutics (50BA) Q2 2024 Earnings Report
DE:50BA Q2 2024 EPS Results
- Actual EPS
- -EUR 0.69
- Consensus EPS
- -EUR 0.99
- Beat/Miss
- Beat by +EUR 0.30
- One Year Ago EPS
- -EUR 1.26
DE:50BA Q2 2024 Revenue Results
- Actual Revenue
- EUR 8.36M
- Expected Revenue
- EUR 5.47M
- Beat/Miss
- Beat by +EUR 2.89M
- YoY Revenue Growth
- -18.04%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/06/2024
- Time
- Before Open
- Conference Call
- Tuesday, August 6, 2024
DE:50BA Upcoming Earnings
Bicycle Therapeutics's next earnings date is estimated for March 2, 2027, based on past reporting schedules.
Q2 2024 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:50BA Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 02, 2027 | 2026 (Q4) | -0.39- | -0.26 | ― | ― |
| Oct 29, 2026 | 2026 (Q3) | -0.36-0.13 | -0.76 | 82.35% (+0.62) | |
| Jul 30, 2026 | 2026 (Q2) | -0.51-0.64 | -1.02 | 36.84% (+0.37) | |
| Apr 30, 2026 | 2026 (Q1) | -0.55-0.78 | -0.79 | 1.14% (+0.01) | |
| Mar 17, 2026 | 2025 (Q4) | -0.84-0.26 | -0.67 | 61.33% (+0.41) | |
| Oct 30, 2025 | 2025 (Q3) | -0.96-0.76 | -0.66 | -14.86% (-0.10) | |
| Aug 08, 2025 | 2025 (Q2) | -0.84-1.02 | -0.69 | -48.05% (-0.33) | |
| May 01, 2025 | 2025 (Q1) | -0.75-0.79 | -0.55 | -41.94% (-0.23) | |
| Feb 25, 2025 | 2024 (Q4) | -0.76-0.67 | -1.04 | 35.34% (+0.37) | |
| Oct 31, 2024 | 2024 (Q3) | -0.71-0.66 | -1.12 | 41.27% (+0.46) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed